Regenerative Medicines: Bone and Joint Applications Global Market Report 2022-2027: Featuring Key Players Bioventus, Conmed, Depuy Synthes Products, Medtronic, Seikagaku & Others

27 Jun 2022
www.prnewswire.com
Gene TherapyCell TherapyAcquisitionCollaborate
DUBLIN, June 27, 2022 /PRNewswire/ -- The "Regenerative Medicines: Bone and Joint Applications" report has been added to
ResearchAndMarkets.com's offering.
An overview of the global market for regenerative medicines for bone and joint applications
Estimation of the market size and analyses of global market trends, with data from 2020 to 2021, estimates for 2022, with projections of compound annual growth rates (CAGRs) through 2027
Characterization and quantification of market potential for regenerative medicines by technology, application, and region
Coverage and discussion on regulatory delays due to COVID-19, clinical trials and product launches of the industry
Description of principle approaches to regenerative medicine and discussion on importance of scaffolding in tissue engineering
Information on major drivers and regional dynamics of the market and current trends within the industry
Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships and other key market strategies
Reasons for Doing This Study:
The purpose of this report is to provide a summary of regenerative medicine products for the treatment of diseases and disorders of the bones and joints. Regenerative therapies have the potential to progress medical outcomes, improve quality of life and decrease overall healthcare costs.
A major objective is the utilization of living cells to repair or replace body tissue damaged by injury, disorder or the ageing process. The most successful products draw upon multidisciplinary fields such as biology, medicine, engineering and, particularly, biomedical engineering.
This report is designed to be a critical decision-making tool for the intended audience, which includes biopharmaceutical market players, potential market entrants and other professionals involved with or interested in cell and gene therapy and regenerative therapy in orthopedic sector.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Principal Approaches to Regenerative Medicine
Cells and Tissues
Tissue Engineering
Importance of Scaffolding in Tissue Engineering
Blood Vessel Scaffolding
Center for Integration of Medicine and Innovative Technology (Cimit)
Embryonic Stem Cells
Chapter 4 Impact of Covid-19
Overview
Impact of Covid-19 on Cell and Gene Therapies, and Regenerative Medicine for Bone and Joint Applications
Direct Impact on Clinical Trials in Cell and Gene Therapy
Chapter 5 Market Dynamics
Market Drivers
Rising Number of Bone and Joint Disorders and Orthopedic Surgeries
Increasing Product Approvals and Launches
R&D for Stem and Gene Therapies
Market Restraints
Stringent Government Regulatory Settings in R&D
Market Opportunities
Growing Pipeline for Regenerative Medicines
Competitive Landscape
Chapter 6 Market Breakdown by Technology
Global Market by Technology
Biomaterials
Biomaterials for Regeneration
Market Size and Forecast
Stem Cell Therapy
Market Size and Forecast
Tissue Engineering
Market Size and Forecast
Chapter 7 Market Breakdown by Application
Global Market by Application
Allogeneic Bones
Market Size and Forecast
Autogenic Bones
Market Size and Forecast
Bone Graft Substitutes
Market Size and Forecast
Market Size and Forecast
Other Diseases
Market Size and Forecast
Chapter 8 Market Breakdown by Region
For more information about this report visit https://www.researchandmarkets.com/r/tgs66
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.